Cardinal Health Stock-Based Compensation 2010-2025 | CAH

Cardinal Health annual/quarterly stock-based compensation history and growth rate from 2010 to 2025. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
  • Cardinal Health stock-based compensation for the quarter ending March 31, 2025 was $91M, a 3.41% increase year-over-year.
  • Cardinal Health stock-based compensation for the twelve months ending March 31, 2025 was $302M, a 11.85% increase year-over-year.
  • Cardinal Health annual stock-based compensation for 2024 was $0.121B, a 26.04% increase from 2023.
  • Cardinal Health annual stock-based compensation for 2023 was $0.096B, a 18.52% increase from 2022.
  • Cardinal Health annual stock-based compensation for 2022 was $0.081B, a 8.99% decline from 2021.
Cardinal Health Annual Stock-Based Compensation
(Millions of US $)
2024 $121
2023 $96
2022 $81
2021 $89
2020 $90
2019 $82
2018 $85
2017 $96
2016 $111
2015 $110
2014 $96
2013 $93
2012 $85
2011 $80
2010 $100
2009 $110
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $36.816B $226.827B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.604B 21.88
Becton Dickinson (BDX) United States $50.274B 12.45
Straumann Holding AG (SAUHY) Switzerland $21.909B 0.00
Labcorp (LH) United States $20.885B 16.94
Cooper (COO) United States $16.582B 22.00
West Pharmaceutical Services (WST) United States $15.565B 32.63
Align Technology (ALGN) United States $13.648B 27.09
Henry Schein (HSIC) United States $8.770B 15.04
Merit Medical Systems (MMSI) United States $5.841B 28.24
DENTSPLY SIRONA (XRAY) United States $3.328B 9.94
CONMED (CNMD) United States $1.865B 13.96
STAAR Surgical (STAA) United States $0.952B 0.00
Lifevantage (LFVN) United States $0.169B 17.39
Pro-Dex (PDEX) United States $0.141B 15.40